Related Experiment Video
Updated: Jul 19, 2026
Isolation of Mouse Megakaryocyte Progenitors
Published on: May 20, 2021
Expression analysis of primary mouse megakaryocyte differentiation and its application in identifying stage-specific
Zhao Chen1, Michael Hu, Ramesh A Shivdasani
1Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Brigham & Women's Hospital, Boston, MA 02115, USA.
Abstract:
Megakaryocyte (MK) differentiation is well described in morphologic terms but its molecular counterparts and the basis for platelet release are incompletely understood. We profiled mRNA expression in populations of primary mouse MKs representing successive differentiation stages. Genes associated with DNA replication are highly expressed in young MKs, in parallel with endomitosis. Intermediate stages are characterized by disproportionate expression of genes associated with the cytoskeleton, cell migration, and G-protein signaling, whereas terminally mature MKs accumulate hemostatic factors, including many membrane proteins. We used these expression profiles to extract a reliable panel of molecular markers for MKs of early, intermediate, or advanced differentiation and establish the value of this marker panel using mouse models of defective thrombopoiesis resulting from absence of GATA1, NF-E2, or tubulin beta1. Computational analysis of the promoters of late-expressed MK genes identified new candidate targets for NF-E2, a critical transcriptional regulator of platelet release. One such gene encodes the kinase adaptor protein LIMS1/PINCH1, which is highly expressed in MKs and platelets and significantly reduced in NF-E2-deficient cells. Transactivation studies and chromatin immunoprecipitation implicate Lims1 as a direct target of NF-E2 regulation. Attribution of stage-specific genes, in combination with various applications, thus constitutes a powerful way to study MK differentiation and platelet biogenesis.
Insights
Researchers identified key molecular markers for megakaryocyte (MK) differentiation stages. This study advances understanding of platelet production by revealing stage-specific gene expression and regulation by NF-E2.
Area of Science:
- Hematology
- Molecular Biology
- Cell Biology
Background:
- Megakaryocyte (MK) differentiation and platelet release mechanisms are not fully understood at the molecular level.
- Existing knowledge primarily relies on morphological descriptions.
Purpose of the Study:
- To profile mRNA expression across MK differentiation stages.
- To identify molecular markers for distinct MK differentiation phases.
- To elucidate the transcriptional regulation of platelet biogenesis.
Main Methods:
- Primary mouse MKs were profiled for mRNA expression at successive differentiation stages.
- Computational promoter analysis was used to identify transcriptional targets.
- Mouse models with defective thrombopoiesis were utilized to validate marker panels.
- Transactivation studies and chromatin immunoprecipitation were performed.
Main Results:
- Distinct gene expression profiles were observed for early, intermediate, and mature MKs.
- Genes for DNA replication dominate early stages, cytoskeleton/signaling genes in intermediate stages, and hemostatic factors in mature MKs.
- A panel of molecular markers for MK differentiation was established.
- LIMS1/PINCH1 was identified as a direct NF-E2 target gene crucial for MKs and platelets.
Conclusions:
- Stage-specific gene expression profiling provides a powerful tool for studying MK differentiation and platelet biogenesis.
- NF-E2 plays a critical role in regulating genes involved in terminal MK differentiation and platelet formation.
- The identified molecular markers and regulatory insights can advance research in thrombopoiesis.
